Business
Update on Revolving Credit Facility
Update on Revolving Credit Facility.
About this update from Kromek Group Plc
[{"type":"text","content":"\n\n6 September 2023\n \nKromek Group plc\n(\"Kromek\" or the \"Group\")\n \nUpdate on Revolving Credit Facility\n \nKromek (AIM: KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN detection segments, provides the following update on the revolving credit facility (\"RCF\") with HSBC.\n \nIn the full year results statement issued on 24 July 2023, Kromek stated that the repayment date of its £5.0m RCF with HSBC was extended by the bank to 31 August 2023. The Group is pleased to announce that the repayment date has been extended to 30 September 2023 as the Group finalises terms to refinance the borrowing facility.\n \nKromek will make a further announcement in due course.\n \n \nFor further information, please contact: \n \n\n\n\nKromek Group plc \n\n\n\n\n\n\n\nArnab Basu, CEO \nPaul Farquhar, CFO \n\n\n+44 (0)1740 626 060 \n\n\n\n\n \n\n\n\n\n\n\n\nfinnCap Ltd (Nominated Adviser and Joint Broker) \n\n\n \n\n\n\n\nGeoff Nash/Seamus Fricker/George Dollemore - Corporate Finance \nTim Redfern/Charlotte Sutcliffe - ECM \n\n\n+44 (0)20 7220 0500 \n \n\n\n\n\n\n\n\n\n\n\n\n\nCenkos Securities plc (Joint Broker)\n\n\n\n\n\n\n\nGiles Balleny - Corporate Finance\nMichael Johnson/Tamar Cranford-Smith - Sales\n\n\n+44 (0)20 7397 8900\n\n\n\n\n\n\n\n\n\n\n\n\nGracechurch Group (Financial PR) \n\n\n\n\n\n\n\nHarry Chathli/Claire Norbury/Henry Gamble \n\n\n+44 (0)20 4582 3500 \n\n\n\n \n \nKromek Group plc \n \nKromek Group plc is a leading developer of radiation detection and bio-detection technology solutions for the advanced imaging and CBRN detection segments. Headquartered in County Durham, UK, Kromek has manufacturing operations in the UK and US, delivering on the vision of enhancing the quality of life through innovative detection technology solutions. \n \nThe advanced imaging segment comprises the medical (including CT and SPECT), security and industrial markets. Kromek provides its OEM customers with detector components, based on its core cadmium zinc telluride (CZT) platform, to enable better detection of diseases such as cancer and Alzheimer's, contamination in industrial manufacture and explosives in aviation...